ALEC Alector Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ALEC

Price (delayed)

$16.59

Market cap

$1.31B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.24

Enterprise value

$1.27B

Sector: Healthcare
Industry: Biotechnology
Website: https://alector.com

Highlights

The debt has contracted by 4.4% YoY
The equity has increased by 42% YoY but it has decreased by 13% QoQ
ALEC's EPS is up by 18% YoY but it is down by 10% from the previous quarter
Alector's net income has shrunk by 83% YoY and by 14% QoQ
The quick ratio has contracted by 15% from the previous quarter

Key stats

What are the main financial stats of ALEC
Market
Shares outstanding
79.24M
Market cap
$1.31B
Enterprise value
$1.27B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.24
Price to sales (P/S)
58.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
57.28
Earnings
Revenue
$22.25M
EBIT
-$168.58M
EBITDA
-$160.1M
Free cash flow
-$153.72M
Per share
EPS
-$2.24
Free cash flow per share
-$1.95
Book value per share
$3.91
Revenue per share
$0.28
TBVPS
$6.75
Balance sheet
Total assets
$531.59M
Total liabilities
$221.4M
Debt
$45.99M
Equity
$310.19M
Working capital
$398.93M
Liquidity
Debt to equity
0.15
Current ratio
6.61
Quick ratio
6.52
Net debt/EBITDA
0.25
Margins
EBITDA margin
-719.7%
Gross margin
100%
Net margin
-757.8%
Operating margin
-785.6%
Efficiency
Return on assets
-31.4%
Return on equity
-53.9%
Return on invested capital
-41.4%
Return on capital employed
-36.6%
Return on sales
-757.8%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ALEC stock price

How has the Alector stock price performed over time
Intraday
2.34%
1 week
-1.66%
1 month
-0.66%
1 year
-27.65%
YTD
9.65%
QTD
9.65%

Financial performance

How have Alector's revenue and profit performed over time
Revenue
$22.25M
Gross profit
$22.25M
Operating income
-$174.76M
Net income
-$168.58M
Gross margin
100%
Net margin
-757.8%
The net margin has plunged by 100% YoY but it has grown by 2.3% from the previous quarter
ALEC's operating margin has dropped by 89% year-on-year but it is up by 3.6% since the previous quarter
Alector's net income has shrunk by 83% YoY and by 14% QoQ
ALEC's operating income has dropped by 73% year-on-year and by 13% since the previous quarter

Growth

What is Alector's growth rate over time

Valuation

What is Alector stock price valuation
P/E
N/A
P/B
4.24
P/S
58.74
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
57.28
ALEC's EPS is up by 18% YoY but it is down by 10% from the previous quarter
The equity has increased by 42% YoY but it has decreased by 13% QoQ
ALEC's P/B is 12% below its last 4 quarters average of 4.8
The revenue has increased by 17% since the previous quarter but it has declined by 9% year-on-year
The stock's price to sales (P/S) is 12% less than its last 4 quarters average of 66.8

Efficiency

How efficient is Alector business performance
ALEC's ROS has plunged by 100% YoY but it is up by 2.3% from the previous quarter
The return on invested capital has dropped by 52% year-on-year and by 9% since the previous quarter
Alector's ROA has decreased by 47% YoY and by 10% from the previous quarter
The return on equity has increased by 8% year-on-year but it has declined by 6% since the previous quarter

Dividends

What is ALEC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ALEC.

Financial health

How did Alector financials performed over time
ALEC's total assets is 140% greater than its total liabilities
ALEC's total assets is up by 18% year-on-year but it is down by 7% since the previous quarter
ALEC's total liabilities is down by 4.2% year-on-year but it is up by 2.2% since the previous quarter
The debt is 85% less than the equity
The equity has increased by 42% YoY but it has decreased by 13% QoQ
The debt to equity is down by 32% year-on-year but it is up by 15% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.